Page last updated: 2024-09-04

butylscopolammonium bromide and Agranulocytosis

butylscopolammonium bromide has been researched along with Agranulocytosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hino, M; Koh, KR; Nakamae, H; Nakane, T; Nakao, T; Terada, Y; Yamane, T; Yoshida, N1
Hopen, G; Ly, B; Moen, T1

Other Studies

2 other study(ies) available for butylscopolammonium bromide and Agranulocytosis

ArticleYear
[Chronic myelogenous leukemia complicated by drug-induced agranulocytosis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:5

    Topics: Aged; Agranulocytosis; Benzamides; Butylscopolammonium Bromide; Colonoscopy; Female; Flumazenil; Granulocyte Colony-Stimulating Factor; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutropenia; Piperazines; Premedication; Pyrimidines; Treatment Outcome

2011
[Agranulocytosis caused by foreign analgesics (Optalidon and Nolotil)].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1979, May-10, Volume: 99, Issue:13

    Topics: Administration, Oral; Agranulocytosis; Aminopyrine; Analgesics; Barbiturates; Butylscopolammonium Bromide; Caffeine; Dipyrone; Drug Combinations; Female; Humans; Middle Aged; Nonprescription Drugs; Pyrazoles; Spain

1979